https://www.onscope.com/ipowner/en/owner/ip/875899-mesoblast-international-sarl.html
Not sure if this has been posted. Patent IP
1.
STEM CELL COMPOSITION
Application Number 16434726 Status Pending Filing Date 2019-06-07 First Publication Date 2019-11-14 Owner Mesoblast International Sarl (Switzerland) Inventor
- Itescu, Silviu
- Simmons, Paul
Abstract
The disclosure provides stem cells which express high levels of Angeopoetin-1 (Ang1) and methods for their production. Such stem cells may be used in a range of therapeutic applications.IPC Classes?
- C12N 5/0775- Mesenchymal stem cells; Adipose-tissue derived stem cells
- A61K 35/28- Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
2.
Miscellaneous Design
Application Number 1501237 Status Registered Filing Date 2019-09-18 Registration Date 2019-09-18 Owner Mesoblast International Sàrl (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. Scientific research, clinical research, and development services in relation to pharmaceutical preparations and medicines; advisory and consultancy services in the fields of pharmaceutical research and development.
3.
Stylized Arc Design
Application Number 199820200 Status Pending Filing Date 2019-09-18 Owner Mesoblast International Sàrl (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
(1) Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. (1) Scientific research, clinical research, and development services in relation to pharmaceutical preparations and medicines; advisory and consultancy services in the fields of pharmaceutical research and development.
4.
Stylized six-point Design
Application Number 199936800 Status Pending Filing Date 2019-09-18 Owner Mesoblast International Sàrl (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
(1) Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. (1) Scientific research, clinical research, and development services in relation to pharmaceutical preparations and medicines; advisory and consultancy services in the fields of pharmaceutical research and development.
5.
Miscellaneous Design
Application Number 1499741 Status Registered Filing Date 2019-09-18 Registration Date 2019-09-18 Owner Mesoblast International Sàrl (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. Scientific research, clinical research, and development services in relation to pharmaceutical preparations and medicines; advisory and consultancy services in the fields of pharmaceutical research and development.
6.
RYONCIL
Application Number 199079300 Status Pending Filing Date 2019-08-23 Owner MESOBLAST INTERNATIONAL SARL (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
(1) Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. (1) Scientific research, clinical research and development in relation to pharmaceutical preparations and medicines; Advisory and consultancy services in the fields of pharmaceutical research and development.
7.
RYONCIL
Application Number 1492588 Status Registered Filing Date 2019-08-23 Registration Date 2019-08-23 Owner MESOBLAST INTERNATIONAL SARL (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. Scientific research, clinical research and development in relation to pharmaceutical preparations and medicines; Advisory and consultancy services in the fields of pharmaceutical research and development.
8.
MESENCHYMAL STEM CELLS AND USES THEREFOR
Application Number 16214485 Status Pending Filing Date 2018-12-10 First Publication Date 2019-08-08 Owner Mesoblast International Sarl (Switzerland) Inventor
- Aggarwal, Sudeepta
- Pittenger, Mark F.
- Varney, Timothy
Abstract
Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.IPC Classes?
- A61K 35/28- Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 38/20- Interleukins
- A61K 45/06- Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C12N 5/0775- Mesenchymal stem cells; Adipose-tissue derived stem cells
9.
RENUMESC
Application Number 198942400 Status Pending Filing Date 2019-08-06 Owner Mesoblast International Sàrl (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
(1) Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. (1) Scientific research, clinical research, and development services in relation to pharmaceutical preparations and medicines; advisory and consultancy services in the fields of pharmaceutical research and development.Continues here https://www.onscope.com/ipowner/en/owner/ip/875899-mesoblast-international-sarl.html
10.
RENUMESC
Application Number 1491190 Status Registered Filing Date 2019-08-06 Registration Date 2019-08-06 Owner Mesoblast International Sàrl (Switzerland) NICE Classes ?
- 05 - Pharmaceutical, veterinary and sanitary products
- 42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Goods & Services
Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. Scientific research, clinical research, and development services in relation to pharmaceutical preparations and medicines; advisory and consultancy services in the fields of pharmaceutical research and development.
- Forums
- ASX - By Stock
- MSB
- MSB Trading - 2020
MSB Trading - 2020, page-684
- There are more pages in this discussion • 22,477 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.19 |
Change
0.030(2.60%) |
Mkt cap ! $1.364B |
Open | High | Low | Value | Volume |
$1.20 | $1.21 | $1.17 | $15.70M | 13.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 35776 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 2400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35776 | 1.300 |
1 | 40541 | 1.280 |
1 | 4068 | 1.250 |
2 | 5921 | 1.245 |
4 | 7073 | 1.220 |
Price($) | Vol. | No. |
---|---|---|
1.125 | 8992 | 2 |
1.140 | 1694 | 1 |
1.150 | 241 | 1 |
1.160 | 200259 | 4 |
1.165 | 14205 | 3 |
Last trade - 15.59pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.19 |
  |
Change
0.030 ( 3.40 %) |
|||
Open | High | Low | Volume | ||
$1.21 | $1.21 | $1.17 | 2927691 | ||
Last updated 15.59pm 07/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online